Document Classification

Section Type: METHODS

Text: Within a multi-centre, randomised phase II trial, 95 patients with LAPC were assigned to three different chemoradiotherapy (CRT) regimens : patients received conventionally fractionated radiotherapy of 50 Gy and were randomised to concurrent 5-fluorouracil (350 mg m (-2) per day on each day of radiotherapy, RT-5-FU arm), concurrent gemcitabine (300 mg m (-2)), and cisplatin (30 mg m (-2)) on days 1, 8, 22, and 29 (RT-GC arm), or the same concurrent treatment followed by sequential full-dose gemcitabine (1000 mg m (-2)) and cisplatin (50 mg m (-2)) every 2 weeks (RT-GC + GC arm).